美国癫痫中心SE治疗方案存在差异
该研究分析了256份来自美国三级和四级癫痫中心的癫痫持续状态(SE)治疗方案,发现仅66%的方案详细规定了治疗时间窗,4%的初始苯二氮䓬类剂量低于推荐,14%的首个非苯二氮䓬类药物剂量低于推荐,61%的方案概述了输注治疗。研究提示尽管及时处理对SE至关重要,但三分之一的机构方案未明确治疗时间。
要点
- 仅66%的SE方案详细规定了治疗时间,三分之一未明确时间窗。
- 4%的方案初始苯二氮䓬剂量低于推荐,14%的首个非苯二氮䓬剂量低于推荐。
- 61%的方案概述了输注治疗管理。
核心结论
- 尽管及时处理对SE管理至关重要,但三分之一的机构方案未明确治疗时间。
- 该分析提供了关于输注治疗管理的专家意见,并突出了SE治疗中需改进的差距和目标。
研究设计与样本
- 分析来自三级和四级癫痫中心的SE治疗方案。
- 共纳入256份SE治疗方案。
- 从每份方案中收集稳定措施、治疗阶段时机、药物、剂量和给药途径等离散数据。
- 分类变量用频率描述,连续变量用中位数描述。
- 将治疗时间和剂量分布与AES指南进行比较。
主要发现
- 仅66%的SE方案详细规定了治疗时间。
- 4%的方案初始苯二氮䓬类剂量低于推荐。
- 14%的方案首个非苯二氮䓬类药物剂量低于推荐。
- 61%的方案概述了输注治疗。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Status epilepticus (SE) is a neurologic emergency that requires urgent recognition and medical management. SE management remains heterogeneous across centers. METHODS: We analyzed SE treatment protocols from level 3 and level 4 epilepsy centers. Discrete data including stabilization measures, timing of treatment phases, medications, doses, and routes of administration were collected from each protocol and described using frequency for categorical variables and median for continuous variables. The distribution of treatment times and dosing were compared with the AES guideline. RESULTS: A total of 256 SE treatment protocols were included. Only 66% of SE protocols detailed treatment times. Doses below recommendations occurred in 4% of protocols for initial benzodiazepine (BZD) and 14% for first non-BZD medications. Infusion therapy was outlined in 61% of protocols. DISCUSSION: Despite the importance of timeliness in SE management, one third of institutional protocols did not specify treatment times. This analysis of US hospital inpatient SE protocols provides expert opinion regarding infusion therapy management and highlights gaps and targets for improvement in SE treatment.
引用
- Lamberta LK, Asmar M, Fredwall MM, et al. Status Epilepticus Protocol Variation Across Accredited National Association of Epilepsy Centers Members. Neurology. 2025. PMID: 40378375. doi:10.1212/WNL.0000000000213689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。